ACWA Power Company (TADAWUL:2082)

Verve Therapeutics Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	156,402	294,050	187,893	111,127	61,412	-
Market Cap Growth	-27.85%	56.50%	69.08%	80.95%	-	-
Enterprise Value	184,282	317,022	211,301	130,632	84,337	-
PE Ratio	91.95	167.35	113.07	72.16	80.93	-
PS Ratio	21.73	46.70	30.83	21.06	11.73	-
PB Ratio	6.53	12.10	9.07	5.55	4.29	-
P/FCF Ratio	-	-	-	82.41	53.44	-
P/OCF Ratio	44.79	84.65	56.17	38.17	19.18	-
EV/Sales Ratio	25.60	50.34	34.67	24.76	16.11	-
EV/EBITDA Ratio	44.43	147.97	73.33	50.83	36.83	-
EV/EBIT Ratio	50.50	193.16	86.72	61.70	50.06	-
EV/FCF Ratio	-194.83	-	-	96.87	73.39	-
Debt / Equity Ratio	1.24	1.12	1.28	1.23	1.79	2.92
Debt / EBITDA Ratio	8.73	12.61	9.14	9.52	11.12	9.31
Debt / FCF Ratio	-	-	-	18.23	22.31	51.74
Quick Ratio	1.73	1.34	1.19	2.16	1.52	0.46
Current Ratio	1.84	1.93	1.80	2.63	1.90	0.75
Asset Turnover	0.13	0.11	0.12	0.11	0.13	0.13
Return on Equity (ROE)	9.09%	8.83%	8.73%	7.33%	7.44%	9.80%
Return on Assets (ROA)	3.16%	1.83%	2.93%	2.80%	2.57%	2.96%
Return on Capital (ROIC)	3.55%	2.08%	3.32%	3.13%	3.05%	3.61%
Return on Capital Employed (ROCE)	5.40%	3.20%	5.20%	4.70%	4.10%	6.00%
Earnings Yield	1.11%	0.60%	0.88%	1.39%	1.24%	-
Earnings Yield	1.11%	0.60%	0.88%	1.39%	1.24%	-
FCF Yield	-0.60%	-0.31%	-0.18%	1.21%	1.87%	-
Dividend Yield	0.20%	-	0.18%	0.55%	0.94%	-
Payout Ratio	3.60%	18.72%	36.52%	40.62%	119.39%	122.65%
Buyback Yield / Dilution	0.01%	0.04%	0.00%	-9.99%	-2.93%	-
Total Shareholder Return	0.22%	0.04%	0.18%	-9.44%	-2.00%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.